Bupropion hydrochloride (XL)
- Product NDC
- 70934-723
- 11-digit product format
- 709340723
- Labeler code
- 70934
- Product ID
- 70934-723_a9dc834e-6710-e166-e053-2995a90a1f00
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA208652
- Marketing category
- ANDA
- Marketing start
- 2020-05-20
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-723-90 | 70934072390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-723-90) | 2020-05-20 | 0000-00-00 | No | No | Current |